174 related articles for article (PubMed ID: 25721243)
1. Predicting concentrations of cytostatic drugs in sewage effluents and surface waters of Catalonia (NE Spain).
Franquet-Griell H; Gómez-Canela C; Ventura F; Lacorte S
Environ Res; 2015 Apr; 138():161-72. PubMed ID: 25721243
[TBL] [Abstract][Full Text] [Related]
2. Determination of cytostatic drugs in Besòs River (NE Spain) and comparison with predicted environmental concentrations.
Franquet-Griell H; Cornadó D; Caixach J; Ventura F; Lacorte S
Environ Sci Pollut Res Int; 2017 Mar; 24(7):6492-6503. PubMed ID: 28074365
[TBL] [Abstract][Full Text] [Related]
3. An environmental risk assessment for oseltamivir (Tamiflu) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions.
Straub JO
Ecotoxicol Environ Saf; 2009 Sep; 72(6):1625-34. PubMed ID: 19560203
[TBL] [Abstract][Full Text] [Related]
4. New insights on cytostatic drug risk assessment in aquatic environments based on measured concentrations in surface waters.
Gouveia TIA; Alves A; Santos MSF
Environ Int; 2019 Dec; 133(Pt B):105236. PubMed ID: 31675568
[TBL] [Abstract][Full Text] [Related]
5. Predicting concentrations of the cytostatic drugs cyclophosphamide, carboplatin, 5-fluorouracil, and capecitabine throughout the sewage effluents and surface waters of Europe.
Johnson AC; Oldenkamp R; Dumont E; Sumpter JP
Environ Toxicol Chem; 2013 Sep; 32(9):1954-61. PubMed ID: 23893496
[TBL] [Abstract][Full Text] [Related]
6. Anticancer drugs in surface waters: what can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs?
Besse JP; Latour JF; Garric J
Environ Int; 2012 Feb; 39(1):73-86. PubMed ID: 22208745
[TBL] [Abstract][Full Text] [Related]
7. A preliminary study on the occurrence of cytostatic drugs in hospital effluents in Beijing, China.
Yin J; Shao B; Zhang J; Li K
Bull Environ Contam Toxicol; 2010 Jan; 84(1):39-45. PubMed ID: 19795089
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Calculation of Predicted Environmental Concentrations to Assess the Risk of Anticancer Drugs in Environmental Waters.
Dominguez-García P; Gibert M; Lacorte S; Gómez-Canela C
Molecules; 2022 May; 27(10):. PubMed ID: 35630679
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of sulfonamide residues along the Ebro River basin: removal in wastewater treatment plants and environmental impact assessment.
García-Galán MJ; Díaz-Cruz MS; Barceló D
Environ Int; 2011 Feb; 37(2):462-73. PubMed ID: 21183221
[TBL] [Abstract][Full Text] [Related]
10. Cytostatic pharmaceuticals as water contaminants.
Jureczko M; Kalka J
Eur J Pharmacol; 2020 Jan; 866():172816. PubMed ID: 31758938
[TBL] [Abstract][Full Text] [Related]
11. Estimation of the cancer risk to humans resulting from the presence of cyclophosphamide and ifosfamide in surface water.
Kümmerer K; Al-Ahmad A
Environ Sci Pollut Res Int; 2010 Feb; 17(2):486-96. PubMed ID: 19548016
[TBL] [Abstract][Full Text] [Related]
12. Anticancer drugs: Consumption trends in Spain, prediction of environmental concentrations and potential risks.
Franquet-Griell H; Gómez-Canela C; Ventura F; Lacorte S
Environ Pollut; 2017 Oct; 229():505-515. PubMed ID: 28628866
[TBL] [Abstract][Full Text] [Related]
13. Ecotoxicity risk of presence of two cytostatic drugs: Bleomycin and vincristine and their binary mixture in aquatic environment.
Jureczko M; Przystaś W
Ecotoxicol Environ Saf; 2019 May; 172():210-215. PubMed ID: 30710771
[TBL] [Abstract][Full Text] [Related]
14. Wastewater reuse in Mediterranean semi-arid areas: The impact of discharges of tertiary treated sewage on the load of polar micro pollutants in the Llobregat river (NE Spain).
Köck-Schulmeyer M; Ginebreda A; Postigo C; López-Serna R; Pérez S; Brix R; Llorca M; de Alda ML; Petrović M; Munné A; Tirapu L; Barceló D
Chemosphere; 2011 Jan; 82(5):670-8. PubMed ID: 21115189
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of androgens and progestogens in wastewater treatment plants and receiving river waters: comparison to estrogens.
Chang H; Wan Y; Wu S; Fan Z; Hu J
Water Res; 2011 Jan; 45(2):732-40. PubMed ID: 20850861
[TBL] [Abstract][Full Text] [Related]
16. Consumption and occurrence of pharmaceutical and personal care products in the aquatic environment in Spain.
Ortiz de García S; Pinto Pinto G; García Encina P; Irusta Mata R
Sci Total Environ; 2013 Feb; 444():451-65. PubMed ID: 23287535
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters.
Buerge IJ; Buser HR; Poiger T; Müller MD
Environ Sci Technol; 2006 Dec; 40(23):7242-50. PubMed ID: 17180973
[TBL] [Abstract][Full Text] [Related]
18. Anticancer drugs in Portuguese surface waters - Estimation of concentrations and identification of potentially priority drugs.
Santos MSF; Franquet-Griell H; Lacorte S; Madeira LM; Alves A
Chemosphere; 2017 Oct; 184():1250-1260. PubMed ID: 28672724
[TBL] [Abstract][Full Text] [Related]
19. Do cytostatic drugs reach drinking water? The case of mycophenolic acid.
Franquet-Griell H; Ventura F; Boleda MR; Lacorte S
Environ Pollut; 2016 Jan; 208(Pt B):532-6. PubMed ID: 26552545
[TBL] [Abstract][Full Text] [Related]
20. Removal of cytostatic drugs from aquatic environment: a review.
Zhang J; Chang VW; Giannis A; Wang JY
Sci Total Environ; 2013 Feb; 445-446():281-98. PubMed ID: 23337605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
